StockWatch
·
Healthcare Research- Analytics & Technology
Board Meeting30 Jul 2026, 06:50 pm

Indegene Ltd Board Approves Financial Results and ESOP Allotment

AI Summary

Indegene Limited's Board of Directors met on July 30, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The board also approved allotments under the ESOP Scheme 2020. The company's trading window for designated persons will reopen on August 3, 2026. The financial results were accompanied by a limited review report from the auditors with an unmodified opinion and a CFO declaration.

Key Highlights

  • Board approved unaudited standalone and consolidated financial results.
  • Results are for the quarter ended June 30, 2026.
  • Allotment approved under ESOP Scheme 2020.
  • Trading window reopens for designated persons on August 3, 2026.
  • Auditors provided a limited review report with an unmodified opinion.